Clinical trial
Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or…
NCT00123565 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00123565 |
|---|---|
| Title | Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction |
| Official title | A Randomized Dose Ranging Study of Hexadecasaccharide Including Active Control, in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction Scheduled to Undergo Percutaneous Coronary Intervention (SHINE) |
| Acronym | SHINE |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Atherosclerosis |
| Intervention type | Drug |
| Interventions | Hexadecasaccharide (SR123781A) |
| Enrollment | 1,257 |
| Start date | Dec 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jul 25, 2005 |
| Last update posted | Aug 21, 2008 |
| Countries | Argentina, Australia, Belgium, Brazil, Canada, Chile, Czechia, France, India, Mexico, Netherlands, Poland and 6 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: